179894-36-1

Basic information

• Product Name: [1-(tert-butoxycarbonyl)-2,2,4-trimethyl-1,2-dihydroquinolin-6-yl]boronic acid
• CAS NO: 179894-36-1
• Molecular Formula: C₁₇H₂₄BNO₄
• Molecular Weight: 317.1878
• Mol File: 179894-36-1.mol

Chemical Properties

• Boiling Point: 464.626°C at 760 mmHg
• Flash Point: 234.798°C
• Density: 1.17g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.56
• CAS DataBase Reference: [1-(tert-butoxycarbonyl)-2,2,4-trimethyl-1,2-dihydroquinolin-6-yl]boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [1-(tert-butoxycarbonyl)-2,2,4-trimethyl-1,2-dihydroquinolin-6-yl]boronic acid(179894-36-1)
• EPA Substance Registry System: [1-(tert-butoxycarbonyl)-2,2,4-trimethyl-1,2-dihydroquinolin-6-yl]boronic acid(179894-36-1)

Safety Data

• Hazardous Substances Data: 179894-36-1(Hazardous Substances Data)

Upstream product

• 121-43-7 Trimethyl borate 
• 594-19-4 tert.-butyl lithium 
• 179894-35-0 6-Bromo-1-tert-butyloxycarbonyl-1,2-dihydro-2,2,4-trimethylquinoline 

Downstream Products

• 199611-77-3 1,2-dihydro-6-(3-cyano-5-fluorophenyl)-2,2,4-trimethyl-1-t-butoxycarbonylquinoline 
• 179894-80-5 6-(3-Chlorophenyl)-1,2-dihydro-2,2,4-trimethylquinoline 
• 179894-84-9 LG₁₂₀₇₅₃ 
• 179894-44-1 1,2-Dihydro-2,2,4-trimethyl-6-(4-nitrophenyl)quinoline 
• 179896-03-8 LG120830 
• 179896-04-9 6-(3-Cyano-4-fluorophenyl)-1,2-dihydro-2,2,4-trimethylquinoline 
• 179896-11-8 1,2-Dihydro-2,2,4-trimethyl-6-(3-methylphenyl)quinoline 
• 179894-50-9 6-(2-Chlorophenyl)-1,2-dihydro-2,2,4-trimethylquinoline 
• 179896-13-0 1,2-Dihydro-6-(3-methoxyphenyl)-2,2,4-trimethylquinoline 
• 179896-20-9 1,2-Dihydro-2,2,4-trimethyl-6-(3-methylthiophenyl)quinoline 
• 179896-40-3 6-(3-Bromo-2-methylphenyl)-1,2-dihydro-2,2,4-trimethylquinoline 
• 179896-31-2 6-(3-Bromophenyl)-1,2-dihydro-2,2,4-trimethylquinoline 
• 179894-88-3 1,2-Dihydro-2,2,4-trimethyl-6-[4-(trifluoroacetyl)phenyl]quinoline 
• 179896-34-5 6-(3-Bromo-5-fluorophenyl)-1,2-dihydro-2,2,4-trimethylquinoline 

Relevant articles and documents

STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.

STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.

Steroid receptor modulator compounds and methods

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.

STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.

STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.

Tricyclic steroid receptor modulator compounds and methods

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.

Steroid receptor modulator compounds and methods

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiting steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.